Cargando…
Guanfacine monotherapy for ADHD/ASD comorbid with Tourette syndrome: a case report
BACKGROUND: Patients with attention deficit/hyperactivity disorder (ADHD) often experience comorbid conditions, such as autism spectrum disorder (ASD) and Tourette syndrome (TS). Although pharmacotherapies are effective for treating ADHD, they are likely to elicit a variety of adverse effects. It is...
Autores principales: | Okazaki, Kosuke, Yamamuro, Kazuhiko, Iida, Junzo, Kishimoto, Toshifumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410501/ https://www.ncbi.nlm.nih.gov/pubmed/30899317 http://dx.doi.org/10.1186/s12991-019-0226-6 |
Ejemplares similares
-
Evaluating Guanfacine Hydrochloride in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adult Patients: Design, Development and Place in Therapy
por: Ota, Toyosaku, et al.
Publicado: (2021) -
Paliperidone extended release for the treatment of pediatric and adolescent patients with Tourette's disorder
por: Yamamuro, Kazuhiko, et al.
Publicado: (2014) -
Prefrontal dysfunction in pediatric Tourette’s disorder as measured by near-infrared spectroscopy
por: Yamamuro, Kazuhiko, et al.
Publicado: (2015) -
Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities
por: Okazaki, Kosuke, et al.
Publicado: (2016) -
Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report
por: Okazaki, Kosuke, et al.
Publicado: (2017)